ライフサイエンスコーパス: cardiothoracic

1 from 4.1% (upper gastrointestinal) to 16.8% (cardiothoracic).

2 es were general (29%), orthopedic (23%), and cardiothoracic (13%).

3 group of patients with clean procedures (382 cardiothoracic, 167 orthopedic, 61 vascular, and 56 othe

4 s occurred in the gastrointestinal (30.19%), cardiothoracic (19.6%), and the orthopedic (11.13%) cate

5 emnity payments per 1,000 admissions varied (cardiothoracic = $30 US dollars, women's health = $90 US

6 mic patients without diabetic history in the cardiothoracic, (adjusted odds ratio, 2.84 [1.21, 6.63])

7 Cardiothoracic adult intensive care department.

8 ed operative mortality rates were lowest for cardiothoracic and noncardiac thoracic surgeons (7.6% ge

9 ial fibrillation (POAF) is a complication of cardiothoracic and noncardiothoracic surgery.

10 d surgical ICUs; 1 ICU had a predominance of cardiothoracic and vascular surgical patients.

11 cic surgeons (5.1% noncardiac thoracic, 5.2% cardiothoracic, and 6.1% general surgeons) (P < 0.01 for

12 cic surgeons (5.0% noncardiac thoracic, 5.3% cardiothoracic, and 6.1% general surgeons) (P < 0.01 for

13 al, nonteaching-affiliated medical-surgical, cardiothoracic, and coronary units experienced increases

14 nts without diabetic history in the cardiac, cardiothoracic, and neurosurgical intensive care units.

15 mmonly associated with the gastrointestinal, cardiothoracic, and orthopedic procedure categories, and

16 Pediatric anesthesia and cardiothoracic anesthesia have accredited fellowships, a

17 eview board, a retrospective study using the Cardiothoracic Anesthesia Patient Registry was undertake

18 The introduction of Adult Cardiothoracic Anesthesiology fellowship accreditation b

19 all adult cardiac surgery patients in all 16 cardiothoracic centers in The Netherlands from January 1

20 th heater-coolers with cases in a quarter of cardiothoracic centers.

21 A reduction in compliance of the large-sized cardiothoracic (central) arteries is an independent risk

22 ithout clinical information and recorded the cardiothoracic (CT) ratio, vascular pedicle width (VPW),

23 (PCI) at medical facilities without on-site cardiothoracic (CT) surgery has been established in clin

24 donation after circulatory death, history of cardiothoracic disease, diabetes history, and terminal c

25 ith the identification of obvious and subtle cardiothoracic diseases.

26 Cardiothoracic Division, Umea University Hospital, Swede

27 nt days differed by ICU (medical ICU = 55.5, cardiothoracic ICU = 25.3, surgical ICU = 40.2; p < .001

28 Cardiothoracic ICU, tertiary university hospital.

29 Nineteen-bed cardiothoracic ICU.

30 trauma patients) and ICU subtypes (88.6% for cardiothoracic ICUs to 93.5% for medical ICUs).

31 tional radiology) to 63.1% (breast imaging); cardiothoracic imagers were more commonly early career r

32 in 9 minutes on a self-powered treadmill, or cardiothoracic index.

33 apy or early mobilization of patients in the cardiothoracic intensive care unit and its effect on len

34 ysical therapy evaluation and treatment in a cardiothoracic intensive care unit could influence lengt

35 lammation and survival in patients requiring cardiothoracic intensive care.

36 d out in a random order until all 5 clusters-cardiothoracic, neurosurgery, orthopedic, general, and u

37 ion can be used to model case flow through a cardiothoracic operating room and ICU.

38 characteristics including age, weight, prior cardiothoracic operation, prematurity, chromosomal abnor

39 For each female kidney, liver, or cardiothoracic organ transplant recipient who had had a

40 tality for recipients of a kidney, liver, or cardiothoracic organ, compared with recipients of organs

41 irths in 83%, 69%, and 79% of pregnancies in cardiothoracic organ, liver, and kidney recipients, resp

42 he benefits for the recipients of livers and cardiothoracic organs were less, but there was no disadv

43 ood glucose exceeded 200 mg/dL in 21% of all cardiothoracic patients and in 31% of diabetic patients

44 Coronary care unit boarders and cardiothoracic patients were excluded from analysis.

45 ysis (65 coronary care unit boarders and 189 cardiothoracic patients).

46 Simulations were also performed using a cardiothoracic phantom.

47 The full spectrum of prior cardiothoracic procedures in lung transplant candidates

48 disagreement, an independent board-certified cardiothoracic radiologist blindly interpreted the image

49 test cases, which were blindly reviewed by a cardiothoracic radiologist, who correctly interpreted al

50 Five cardiothoracic radiologists evaluated 1575 low-dose comp

51 odified Lown criteria > or =2 (OR, 5.6), and cardiothoracic ratio > or =0.6 (OR, 3.3).

52 cutoffs of vascular pedicle width >70 mm and cardiothoracic ratio >0.55 or by incorporating clinical

53 ricular dysfunction (ejection fraction <45%, cardiothoracic ratio >0.55, or pulmonary edema on chest

54 In patients with normal heart size (cardiothoracic ratio < or = 0.55), the improvement in de

55 .66 +/- 0.22 versus 0.81 +/- 0.17, P = .02), cardiothoracic ratio (0.53 +/- 0.04 versus 0.58 +/- 0.06

56 d from 20+/-9% to 31+/-11% (P<0.01), and the cardiothoracic ratio decreased from 0.61+/-0.06 to 0.57+

57 ing the objective vascular pedicle width and cardiothoracic ratio measures was 3.1 (95% confidence in

58 jection fraction, higher heart rate, greater cardiothoracic ratio, higher prevalence of left bundle b

59 Cardiothoracic ratio, left ventricular end-diastolic dia

60 exity of underlying cardiac defect, enlarged cardiothoracic ratio, previous thoracotomy/ies, body mas

61 0 mm for vascular pedicle width and 0.55 for cardiothoracic ratio, radiologists' accuracy in differen

62 During 482+/-161 days of follow-up, cardiothoracic ratio, SDNN, left ventricular end-systoli

63 sodium and higher creatinine levels; higher cardiothoracic ratio; nonsustained ventricular tachycard

64 Their left ventricular dimensions, cardiothoracic ratios, and pressure-volume loop analyses

65 ternotomy and stapling resection by the same cardiothoracic surgeon.

66 important" in assessing the performance of a cardiothoracic surgeon.

67 ODS AND Projections of supply and demand for cardiothoracic surgeons are based on analysis of populat

68 grafting, there is a projected shortfall of cardiothoracic surgeons because the active supply is pro

69 By 2025, the demand for cardiothoracic surgeons could increase by 46% on the bas

70 ulation grows and ages, the number of active cardiothoracic surgeons has fallen for the first time in

71 In the United Kingdom, cardiothoracic surgeons have led the outcome reporting r

72 valuates current and future requirements for cardiothoracic surgeons in light of decreasing rates of

73 5, the survey was sent out to all consultant cardiothoracic surgeons in the United Kingdom (n=361).

74 A recent survey suggested that cardiothoracic surgeons may alter planned procedures to

75 9 patients were obtained from the Society of Cardiothoracic Surgeons of Great Britain and Ireland on

76 commendations were made by cardiologists and cardiothoracic surgeons provided with the patients' clin

77 ation model, we project the future supply of cardiothoracic surgeons under alternative assumptions ab

78 to surgeon-specific mortality data among UK cardiothoracic surgeons who associate this with several

79 The United States is facing a shortage of cardiothoracic surgeons within the next 10 years, which

80 The objective of this survey was to assess cardiothoracic surgeons' opinions on the topic, with the

81 oracic surgeons (7.6% general surgeons, 5.6% cardiothoracic surgeons, 5.8% noncardiac thoracic surgeo

82 ith industry, together with bioengineers and cardiothoracic surgeons, adult cardiac interventionists

83 g resection, 36% by general surgeons, 39% by cardiothoracic surgeons, and 25% by noncardiac thoracic

84 , to designate surgeons as general surgeons, cardiothoracic surgeons, or noncardiac thoracic surgeons

85 gists, in conjunction with cardiologists and cardiothoracic surgeons.

86 randomly selected vascular, neurologic, and cardiothoracic surgeons.

87 dents with dry eye syndrome was found in the cardiothoracic surgery (75 %) and otorhinolaryngology (7

88 ciated heart disease (RAHD), often requiring cardiothoracic surgery (CTS).

89 Cardiology and the European Association for Cardiothoracic Surgery (ESC/EACTS) 2012 guidelines recom

90 AF diagnosed during a secondary precipitant, cardiothoracic surgery (n=131 [30%]), infection (n=102 [

91 ediatric surgery (OR 0.583, P = 0.0053), (3) cardiothoracic surgery (OR 0.626, P = 0.0117), and (4) b

92 ns caused by Bipolaris spp. in postoperative cardiothoracic surgery (POCS) patients during January 20

93 invasive Mycobacterium chimaera infection in cardiothoracic surgery and a possible association with c

94 601 massively transfused nontrauma patients, cardiothoracic surgery and gastrointestinal or hepato-pa

95 in urologic oncology, gynecologic oncology, cardiothoracic surgery and now in female pelvic medicine

96 who were discharged from the hospital after cardiothoracic surgery between 1992 and 2002.

97 idental PFO is common in patients undergoing cardiothoracic surgery but is not associated with increa

98 ry 1, 2007, and December 31, 2009, in all 16 cardiothoracic surgery centers in the Netherlands were i

99 om a multicenter, observational study of the Cardiothoracic Surgery Clinical Trials Network, in which

100 Of the 132 patients identified in the Cardiothoracic Surgery database and at discharge from th

101 iety for Cardiology/European Association for Cardiothoracic Surgery guidelines for myocardial revascu

102 nvasive surgery that guided General Surgery, Cardiothoracic Surgery has progressed with warranted ent

103 M. chimaera infection subsequent to cardiothoracic surgery is a novel entity that has been r

104 ep hypothermic circulatory arrest (DHCA) for cardiothoracic surgery is associated with increased risk

105 rd-certified physicians expand their role in cardiothoracic surgery or if patients must delay appropr

106 Among cardiothoracic surgery patients with or at risk for resp

107 atinine during hospitalization after various cardiothoracic surgery procedures.

108 The risk of death associated with AKI after cardiothoracic surgery remains high for 10 years regardl

109 Survival was worse among all subgroups of cardiothoracic surgery with AKI except for valve surgery

110 Among patients undergoing cardiothoracic surgery with median sternotomy, the use o

111 derwent general, gynecologic, neurologic, or cardiothoracic surgery, 3864 were included in the intent

112 One-third had prior cardiothoracic surgery, 91% of the surgeries were electi

113 heart failure/transplant, epidemiology, and cardiothoracic surgery, as well as patient advocates, pa

114 ue to grow, especially in patients following cardiothoracic surgery, bone marrow transplantation, res

115 s to aprotinin is low in children undergoing cardiothoracic surgery, even with multiple exposures to

116 trol participants were attending surgeons in cardiothoracic surgery, general surgery, vascular surger

117 f intermittent diaphragm contractions during cardiothoracic surgery, including controlled mechanical

118 ertension, sepsis, shock, acute lung injury, cardiothoracic surgery, mechanical ventilation, vasopres

119 A total of 830 patients who had undergone cardiothoracic surgery, of which coronary artery bypass,

120 In patients (age 65.6 +/- 6.3 yr) undergoing cardiothoracic surgery, one phrenic nerve was stimulated

121 c approach between the Pediatric Cardiology, Cardiothoracic Surgery, Pediatric Intensive Care, and Ne

122 with pulmonary hypertension associated with cardiothoracic surgery, require therapy for right ventri

123 ng treatments such as resuscitation, complex cardiothoracic surgery, use of experimental treatments,

124 e LivaNova factory seems a likely source for cardiothoracic surgery-related severe M chimaera infecti

125 on, and pulmonary embolism, as well as after cardiothoracic surgery.

126 sensitivity reactions in children undergoing cardiothoracic surgery.

127 morphine crystal accumulation, necessitating cardiothoracic surgery.

128 nly encountered arrhythmia that occurs after cardiothoracic surgery.

129 ve outcomes of patients with hypoxemia after cardiothoracic surgery.

130 is basically feasible in ICU patients after cardiothoracic surgery.

131 e clinical settings--eg, patients undergoing cardiothoracic surgery.

132 lococcus aureus are serious complications of cardiothoracic surgery.

133 al venous access, pacemaker implantation and cardiothoracic surgery.

134 rtension, sepsis, acute lung injury or after cardiothoracic surgery.

135 berculous mycobacterium (NTM), subsequent to cardiothoracic surgery.

136 promise for advancing the field of pediatric cardiothoracic surgery.

137 isk factors for SSIs were diabetes and prior cardiothoracic surgery; procedure-related independent ri

138 into two groups: patients who had undergone cardiothoracic surgical (CTS) procedures prior to LTx (n

139 ped into a routine surgical approach at many cardiothoracic surgical centers.

140 ients with moderate or severe IMR from the 2 Cardiothoracic Surgical Trials Network IMR trials who re

141 ections were significantly more common among cardiothoracic than abdominal transplant recipients (p=0

142 Data from the UK Cardiothoracic Transplant Audit and UK Renal Registry we

143 We used the United Kingdom Cardiothoracic Transplant Audit database to analyze the

144 ited, heterogeneous, observational cohort of cardiothoracic transplant patients who went on to receiv

145 Cardiothoracic transplant programs generally require tha

146 Adult (aged 18+) caregivers of 242 cardiothoracic transplant recipients (lung = 134; heart

147 increased long-term mortality in kidney and cardiothoracic transplant recipients and an increased ri

148 Cardiothoracic transplant recipients are at greatest ris

149 A cohort of 96 cardiothoracic transplant recipients was monitored postt

150 problem for medium-to-long-term survivors of cardiothoracic transplantation.

151 ces both short- and long-term outcomes after cardiothoracic transplantation.

152 imus and everolimus are increasingly used in cardiothoracic transplantation.

153 aft survival and function in all renal after cardiothoracic transplants undertaken in the United King

154 r challenge during organ transplantation and cardiothoracic, vascular and general surgery.